Details checkedClinical trial listing onlyCheckedregistry+publication+company

Synchron Stentrode / SWITCH BCI

Also known as: Synchron BCI, Stentrode, SWITCH BCI, Synchron endovascular BCI, COMMAND BCI

Synchron

Primary source

Company

Synchron

Program Type

Software/Neurotech

Modality

BCI/Neurotech

Stage

Interventional/NA

Status

Active

Target Gene

—

Route / Mode

Endovascular implant plus chest transceiver and external decoding software

Confidence

92%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-10

Geography

United States, Australia, Canada

Population

adult, implantable-bci, communication-accessibility, assistive-technology, motor-intent-decoding, investigational-device

Trial IDs

Mechanism

Endovascular implantable brain-computer interface that places a Stentrode electrode array through blood vessels near motor cortex, decodes motor intent, and converts neural signals into digital commands for communication and device control.

Indications

Communication Impairment Severe Paralysis ALS Locked-In Syndrome

Notes

Communication/accessibility BCI record rather than a hearing-loss treatment. Included because endovascular speech/device-control neurotech is central to the broader BCI side of the device taxonomy; Synchron identifies the device as investigational.

Evidence & Sources

4 structured sources

company

Supports: canonicalName, company, mechanism, status, route, populationTags

Open

clinicaltrials

Supports: aliases, stage, indications, trialIds

IDs: NCT03834857

Open

clinicaltrials

Supports: status, geography, trialIds

IDs: NCT07543367